Signaling Pathways - MARK1 - COX - MK2 - LPA Receptors
清除全部
- C5545 MK2 Inhibitor IVTarget: MK2Summary: 高选择性、非ATP竞争性MK2抑制剂
- B6962 CMPD-1Target: Microtubules/Tubulins|MK2Summary: p38α介导的MK2a磷酸化的抑制剂
- B5549 PF-3644022Target: MK2Summary: MK2抑制剂
- B7515 1-Oleoyl lysophosphatidic acid sodium saltTarget: LPA ReceptorsSummary: 激活LPA受体
- B1445 Flunixin Meglumin中文名: 氟尼辛葡甲胺Target: COXSummary: 环氧合酶抑制剂
- B1441 Lornoxicam中文名: 氯诺昔康Target: COXSummary: COX-1/COX-2抑制剂
- B1458 Lumiracoxib中文名: 罗美昔布Target: COXSummary: 新型的选择性COX-2抑制剂
- B1591 Ki16198Target: LPA ReceptorsSummary: LPA拮抗剂
- B2133 Suprofen中文名: 舒洛芬Target: COXSummary: 双重COX-1/COX-2抑制剂
- B1886 Antipyrine中文名: 安替比林Target: COXSummary: 止痛药和解热药